DSFIR logo

DSM-Firmenich Stock Price

Symbol: ENXTAM:DSFIRMarket Cap: €21.6bCategory: Materials

DSFIR Share Price Performance

€82.56
-35.49 (-30.06%)
31.1% undervalued intrinsic discount
€119.85
Fair Value
€82.56
-35.49 (-30.06%)
31.1% undervalued intrinsic discount
€119.85
Fair Value
Price €82.56
AnalystConsensusTarget €119.85

DSFIR Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value €119.85 31.1% undervalued intrinsic discount

Health And Bio-Based Trends Will Drive Future Success

0users have liked this narrative
0users have commented on this narrative
17users have followed this narrative

Recent DSFIR News & Updates

No updates

DSM-Firmenich AG Key Details

€13.0b

Revenue

€8.5b

Cost of Revenue

€4.6b

Gross Profit

€3.8b

Other Expenses

€718.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 12, 2026
Earnings per share (EPS)
2.74
Gross Margin
35.02%
Net Profit Margin
5.52%
Debt/Equity Ratio
25.2%

DSM-Firmenich AG Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About DSFIR

Founded
1902
Employees
28608
CEO
Dimitri de Vreeze
WebsiteView website
www.dsm-firmenich.com

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. The Animal Nutrition & Health segment offers animal proteins, vitamins, performance solutions, and data-driven precision services. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.

Swiss Market Performance

  • 7 Days: 0.2%
  • 3 Months: -0.7%
  • 1 Year: 1.3%
  • Year to Date: 2.5%
Over the last 7 days, the market has dropped 1.5%, driven by a pullback of 3.9% in the Healthcare sector. Overall the market has been flat in the last year. Looking forward, earnings are forecast to grow by 11% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading